DWA
GWPH

Douglass Winthrop Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Douglass Winthrop Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,625
Closed -$227K – 295
2018
Q2 		$227K Buy
+1,625
New +$231K 0.01% 267
2018
Q1 		– Sell
-1,625
Closed -$215K – 277
2017
Q4 		$215K Buy
+1,625
New +$191K 0.01% 232

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Douglass Winthrop Advisors's GWPH Position: Q3 2018 in Review

Douglass Winthrop Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2018, closing a stake of 1,625 shares — an estimated $227K sold.

Douglass Winthrop Advisors first reported a position in GWPH in Q4 2017 and held it in 2 quarters. The position peaked at $227K in Q2 2018. 272 funds tracked by Wall St. Rank hold GWPH as of Q3 2018.

  • Douglass Winthrop Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2018 after selling out during the quarter.
  • Douglass Winthrop Advisors sold 1,625 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2018, an estimated $227K.
  • Douglass Winthrop Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 2 quarters.
  • Douglass Winthrop Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $227K in Q2 2018.
  • 272 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2018.

Based on Douglass Winthrop Advisors's 13F filing for Q3 2018, filed 12 Oct 2018.